Brind.

Polyrizon Ltd. is collaborating with the University of Parma on a study utilizing its proprietary Capture & Contain (C&C) platform.

1 report, 1 independent Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Polyrizon Ltd. is collaborating with the University of Parma on a study utilizing its proprietary Capture & Contain (C&C) platform.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Polyrizon Ltd., involving its Audit Committee, received panel approval for its continued listing request on July 15, 2025.Sub-event
  2. Polyrizon Ltd. partners with University of Parma for research using its C&C technology.1 source

Keep exploring

The entities involved

  • C&C

    German record label

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GlobeNewswirePolyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study Ra’anana, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Compan